Relestat

Relestat Overdosage

epinastine

Manufacturer:

Allergan

Distributor:

DKSH
Full Prescribing Info
Overdosage
After instillation of epinastine HCl 0.3% eye drops 3 times daily (corresponds to 9 times the recommended daily dose), reversible miosis, without influence on visual acuity or other ocular parameters, was observed.
The 5-mL bottle of Relestat contains 2.5 mg of epinastine HCl. A tablet formulation is marketed at a once daily dose of up to 20 mg epinastine HCl, as such, intoxication after oral ingestion of the ophthalmic formulation is not expected even if the whole content of the bottle is swallowed.
No case of overdose with Relestat has been reported.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in